+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prefillable Reusable Injection Devices to 2026

  • ID: 5568489
  • Report
  • April 2022
  • Region: Global
  • 125 Pages
  • Greystone Associates
The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.

What You Will Learn

  • What are the dynamics of the shifting landscape for prefillable reusable injectable drug delivery and the market impact of new and evolving devices
  • What are the market drivers influencing injector device designs, feature/functionality, product branding, competing technologies and commercial development?
  • What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
  • What is the current market for prefillable reusable injector demand and what will it be in 2026?
  • Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
  • What is the impact of economic, technology, and regulatory factors on prefillable reusable injectable drug delivery demand? 
Note: Product cover images may vary from those shown
  1. Executive Summary
  2. Device and Packaging Technology Advances
  3. Shifting Patient Demographics
  4. Evolution in Drug Development
  5. Diseases and Indications
  6. Device Selection Factors
  7. Market Segmentation
  8. Product Features & Ease of Use
  9. Supply Chain Factors
  10. Device Classes
  11. Pen Injectors
  12. Autoinjectors
  13. Therapeutic Segments
  14. Hematopoietics
  15. Antivirals
  16. Hormone Replacement
  17. Parkinson’s Disease
  18. Hematopoietics
  19. Reproductive Health
  20. Market Factors
  21. Regulatory Issues
  22. DTC Marketing
  23. Patient Education
  24. Company Profiles
Note: Product cover images may vary from those shown